CIAM
TYRA icon

Caitong International Asset Management’s Tyra Biosciences TYRA Stock Holding History

Caitong International Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.4K Sell
1,891
-1,106
-37% -$35.8K 0.01% 676
2025
Q4 		$78.8K Buy
+2,997
New +$55K 0.02% 534
2025
Q3 		– Sell
-569
Closed -$5.45K – 2532
2025
Q2 		$5.45K Buy
569
+66
+13% +$627 ﹤0.01% 984
2025
Q1 		$4.68K Buy
+503
New +$6.51K ﹤0.01% 1040

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Caitong International Asset Management's TYRA Position: Q1 2026 in Review

Caitong International Asset Management reduced its Tyra Biosciences (TYRA) stake by 37% in Q1 2026, selling an estimated $35.8K and leaving 1,891 shares worth $72.4K. The position accounts for 0.01% of the portfolio, ranked #676.

Caitong International Asset Management first reported a position in TYRA in Q1 2025 and has held it in 4 quarters since. The position peaked at $78.8K in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Caitong International Asset Management held 1,891 shares of Tyra Biosciences worth $72.4K as of Q1 2026.
  • Caitong International Asset Management sold 1,106 Tyra Biosciences shares in Q1 2026, an estimated $35.8K.
  • Tyra Biosciences made up 0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #676 holding.
  • Caitong International Asset Management first reported a position in Tyra Biosciences in Q1 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's Tyra Biosciences position peaked at $78.8K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.